This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

The Lung Health Study

Nicholas R. Anthonisen, MD; John E. Connett, PhD; James P. Kiley, PhD; Murray D. Altose, MD; William C. Bailey, MD; A. Sonia Buist, MD; William A. Conway, Jr, MD; Paul L. Enright, MD; Richard E. Kanner, MD; Peggy O'Hara, PhD; Gregory R. Owens, MD; Paul D. Scanlon, MD; Donald P. Tashkin, MD; Robert A. Wise, MD; M. D. Altose, MD; A. F. Connors, MD; S. Redline, MD; C. Deitz, PhD; R. F. Rakos, PhD; W. A. Conway, Jr, MD; A. DeHorn, PhD; J. C. Ward, MD; C. S. Hoppe-Ryan, CSW; R. L. Jentons, MA; J. A. Reddick, RN; C. Sawicki, RN, MPH; R. A. Wise, MD; S. Permutt, MD; C. S. Rand, PhD; P. D. Scanlon, MD; L. J. Davis, PhD; R. D. Hurt, MD; R. D. Miller, MD; D. E. Williams, MD; G. M. Caron; G. G. Lauger, MS; S. M. Toogood; A. S. Buist, MD; W. M. Bjornson, MPH; L. R. Johnson, PhD; W. C. Bailey, MD; C. M. Brooks, EdD; J. J. Dolce, PhD; D. M. Higgins; M. A. Johnson; C. D. Lorish, PhD; B. A. Martin; D. P. Tashkin, MD; A. H. Coulson; H. Gong, MD; P. I. Harber, MD; V. C. Li, PhD, MPH; M. Roth, MD; M. A. Nides, PhD; M. S. Simmons; I. Zuniga; N. R. Anthonisen, MD; J. Manfreda, MD; R. P. Murray, PhD; S. C. Rempel-Rossum; J. M. Stoyko; J. E. Connett, PhD; M. O. Kjelsberg, PhD; M. K. Cowles, MS; D. A. Durkin; P. L. Enright, MD; K. J. Kurnow, MS; W. W. Lee, MS; P. G. Lindgren, MS; S. J. Mongin, MS; P. O'Hara, PhD; H. T. Voelker; L. A. Waller, PhD; G. R. Owens, MD; R. M. Rogers, MD; J. J. Johnston, PhD; F. P. Pope, MSW; F. M. Vitale, MA; R. E. Kanner, MD; M. A. Rigdon, PhD; K. C. Benton; P. M. Grant; M. Becklake, MD; B. Burrows, MD; P. Cleary, PhD; P. Kimbel, MD; L. Nett, RN, RRT; J. K. Ockene, PhD; R. M. Senior, MD; G. L. Snider, MD; W. Spitzer, MD; O. D. Williams, PhD; S. S. Hurd, PhD; J. P. Kiley, PhD; M. C. Wu, PhD; S. M. Ayres, MD; R. E. Hyatt, MD; B. A. Mason, MD

JAMA. 1994;272(19):1497-1505.

Abstract
Objective.
—To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 second (FEV₁) in smokers aged 35 to 60 years who have mild obstructive pulmonary disease.

Design.
—Randomized clinical trial. Participants randomized with equal probability to one of the following groups: (1) smoking intervention plus bronchodilator, (2) smoking intervention plus placebo, or (3) no intervention.

Setting.
—Ten clinical centers in the United States and Canada.

Participants.
—A total of 5887 male and female smokers, aged 35 to 60 years, with spirometric signs of early chronic obstructive pulmonary disease.

Interventions.
—Smoking intervention: intensive 12-session smoking cessation program combining behavior modification and use of nicotine gum, with continuing 5-year maintenance program to minimize relapse. Bronchodilator: ipratropium bromide prescribed three times daily (two puffs per time) from a metered-dose inhaler.

Main Outcome Measures.
—Rate of change and cumulative change in FEV₁ over a 5-year period.

Results.
—Participants in the two smoking intervention groups showed significantly smaller declines in FEV₁ than did those in the control group. Most of this difference occurred during the first year following entry into the study and was attributable to smoking cessation, with those who achieved sustained smoking cessation experiencing the largest benefit. The small noncumulative benefit associated with use of the active bronchodilator vanished after the bronchodilator was discontinued at the end of the study.

Conclusions.
—An aggressive smoking intervention program significantly reduces the age-related decline in FEV₁ in middle-aged smokers with mild airways obstruction. Use of an inhaled anticholinergic bronchodilator results in a relatively small improvement in FEV₁ that appears to be reversed after the drug is discontinued. Use of the bronchodilator did not influence the long-term decline of FEV₁.

(JAMA. 1994;272:1497-1505)

Author Affiliations
for the Lung Health Study Research Group; Case Western Reserve University, Cleveland, Ohio; Henry Ford Hospital, Detroit, Mich; Johns Hopkins University School of Medicine, Baltimore, Md; Mayo Clinic, Rochester, Minn; Oregon Health Sciences University, Portland; University of Alabama at Birmingham; University of California—Los Angeles; University of Manitoba, Winnipeg; University of Minnesota Data Coordinating Center, Minneapolis; University of Pittsburgh (Pa); University of Utah, Salt Lake City; Safety and Data Monitoring Board; National Heart, Lung, and Blood Institute staff, Bethesda, Md; Mortality and Morbidity Review Board

From University of Manitoba, Winnipeg (Dr Anthonisen); University of Minnesota, Minneapolis (Dr Connett); National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Kiley); Case Western Reserve University, Cleveland, Ohio (Dr Altose); University of Alabama at Birmingham (Dr Bailey); Oregon Health Sciences University, Portland (Dr Buist); Henry Ford Hospital, Detroit, Mich (Dr Conway); University of Arizona, Tucson (Dr Enright); University of Utah, Salt Lake City (Dr Kanner); University of Miami (Fla) (Dr O'Hara); University of Pittsburgh (Pa) (Dr Owens); Mayo Clinic, Rochester, Minn (Dr Scanlon); University of California— Los Angeles (Dr Tashkin); and The Johns Hopkins University, Baltimore, Md (Dr Wise).

Footnotes
A complete list of the members of the Lung Health Study Research Group appears at the end of this article.

Reprint requests to Lung Health Study, 2221 University Ave SE, Suite 200, Minneapolis, MN 55414 (Dr Connett).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mortality in the 4-Year Trial of Tiotropium (UPLIFT) in Patients with Chronic Obstructive Pulmonary Disease
Celli et al.
Am. J. Respir. Crit. Care Med. 2009;180:948-955.
ABSTRACT | FULL TEXT  

COPD and cancer mortality: the influence of statins
van Gestel et al.
Thorax 2009;64:963-967.
ABSTRACT | FULL TEXT  

Medicare Spending for Previously Uninsured Adults
McWilliams et al.
ANN INTERN MED 2009;0:0000605-200912010-00149v1-E-149.
ABSTRACT | FULL TEXT  

Present and future costs of COPD in Iceland and Norway: results from the BOLD study
Nielsen et al.
Eur Respir J 2009;34:850-857.
ABSTRACT | FULL TEXT  

Smoking cessation interventions in COPD: a network meta-analysis of randomised trials
Strassmann et al.
Eur Respir J 2009;34:634-640.
ABSTRACT | FULL TEXT  

Ethical analysis of the justifiability of labelling with COPD for smoking cessation
Kotz et al.
J. Med. Ethics 2009;35:534-540.
ABSTRACT | FULL TEXT  

Transforming Growth Factor-{beta} Receptor-3 Is Associated with Pulmonary Emphysema
Hersh et al.
Am. J. Respir. Cell Mol. Bio. 2009;41:324-331.
ABSTRACT | FULL TEXT  

The day-to-day process of stopping or reducing smoking: A prospective study of self-changers
Peters and Hughes
Nicotine Tob Res 2009;11:1083-1092.
ABSTRACT | FULL TEXT  

Is COPD Really a Cardiovascular Disease?
Sin
Chest 2009;136:329-330.
FULL TEXT  

Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence
Young et al.
Postgrad. Med. J. 2009;85:414-421.
ABSTRACT | FULL TEXT  

Leptin receptor polymorphisms and lung function decline in COPD
Hansel et al.
Eur Respir J 2009;34:103-110.
ABSTRACT | FULL TEXT  

Association between lung function and disability in African-Americans
Thorpe et al.
J. Epidemiol. Community Health 2009;63:541-545.
ABSTRACT | FULL TEXT  

Investigating the Natural History of Lung Function: Facts, Pitfalls, and Opportunities
Kohansal et al.
Chest 2009;135:1330-1341.
ABSTRACT | FULL TEXT  

Prediction of Chronic Obstructive Pulmonary Disease (COPD) in Asthma Patients Using Electronic Medical Records
Himes et al.
J. Am. Med. Inform. Assoc. 2009;16:371-379.
ABSTRACT | FULL TEXT  

Lung Cancer and Chronic Obstructive Pulmonary Disease: Needs and Opportunities for Integrated Research
Punturieri et al.
JNCI J Natl Cancer Inst 2009;101:554-559.
ABSTRACT | FULL TEXT  

Efficacy of confronting smokers with airflow limitation for smoking cessation
Kotz et al.
Eur Respir J 2009;33:754-762.
ABSTRACT | FULL TEXT  

From large clinical trials to management of COPD in the real world
Cazzola
Ther Adv Respir Dis 2009;3:39-46.
ABSTRACT  

Chronic Obstructive Pulmonary Disease
Braman
ACCP Pulmonary Med Brd Rev 2009;25:153-186.
FULL TEXT  

The of COPD: or balancing repair (yang) and inflammation (yin)
Soriano and Agusti
Eur Respir J 2008;32:1426-1427.
FULL TEXT  

Chronic Obstructive Pulmonary Disease with Lung Cancer and/or Cardiovascular Disease
Rodriguez-Roisin and Soriano
Proc Am Thorac Soc 2008;5:842-847.
ABSTRACT | FULL TEXT  

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Man et al.
Eur Respir J 2008;32:1451-1457.
ABSTRACT | FULL TEXT  

Should we be using statistics to define disease?
Mannino
Thorax 2008;63:1031-1032.
FULL TEXT  

Desmosine as a biomarker of elastin degradation in COPD: current status and future directions
Luisetti et al.
Eur Respir J 2008;32:1146-1157.
ABSTRACT | FULL TEXT  

COPD and Declining FEV1 -- Time to Divide and Conquer?
Reilly
NEJM 2008;359:1616-1618.
FULL TEXT  

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin et al.
NEJM 2008;359:1543-1554.
ABSTRACT | FULL TEXT  

COPD-related morbidity and mortality after smoking cessation: status of the evidence
Godtfredsen et al.
Eur Respir J 2008;32:844-853.
ABSTRACT | FULL TEXT  

Review: Pharmacotherapy for smoking cessation
Carrozzi et al.
Ther Adv Respir Dis 2008;2:301-317.
ABSTRACT  

Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study
Celli et al.
Am. J. Respir. Crit. Care Med. 2008;178:332-338.
ABSTRACT | FULL TEXT  

Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD
He et al.
Eur Respir J 2008;32:25-34.
ABSTRACT | FULL TEXT  

Update on the Management of COPD
Celli
Chest 2008;133:1451-1462.
ABSTRACT | FULL TEXT  

Natural History of Emphysema
Minai et al.
Proc Am Thorac Soc 2008;5:468-474.
ABSTRACT | FULL TEXT  

Multidisciplinary Care of the Patient with Chronic Obstructive Pulmonary Disease
Kuzma et al.
Proc Am Thorac Soc 2008;5:567-571.
ABSTRACT | FULL TEXT  

Pulmonary Function and the Risk of Functional Limitation in Chronic Obstructive Pulmonary Disease
Eisner et al.
Am J Epidemiol 2008;167:1090-1101.
ABSTRACT | FULL TEXT  

Review: Surfactant protein D: A lung specific biomarker in COPD?
Sin et al.
Ther Adv Respir Dis 2008;2:65-74.
ABSTRACT  

Investigation Into the Cause of Death of a 56-Year-Old Man With Serious Mental Illness
Prochaska et al.
Am. J. Psychiatry 2008;165:453-456.
FULL TEXT  

Outcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola et al.
Eur Respir J 2008;31:416-469.
ABSTRACT | FULL TEXT  

External validation of a COPD diagnostic questionnaire
Kotz et al.
Eur Respir J 2008;31:298-303.
ABSTRACT | FULL TEXT  

Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study
Bathoorn et al.
Eur Respir J 2007;30:1131-1137.
ABSTRACT | FULL TEXT  

Effect of Occupational Exposures on Decline of Lung Function in Early Chronic Obstructive Pulmonary Disease
Harber et al.
Am. J. Respir. Crit. Care Med. 2007;176:994-1000.
ABSTRACT | FULL TEXT  

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline from the American College of Physicians
Qaseem et al.
ANN INTERN MED 2007;147:633-638.
ABSTRACT | FULL TEXT  

Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice Guideline
Wilt et al.
ANN INTERN MED 2007;147:639-653.
ABSTRACT | FULL TEXT  

Too little, too late the patients' perspective on education for COPD
Jones
Chronic Respiratory Disease 2007;4:189-190.
 

Smoking cessation and transition into retirement: analyses from the English Longitudinal Study of Ageing
Lang et al.
Age Ageing 2007;36:638-643.
ABSTRACT | FULL TEXT  

Review: Systemic consequences of COPD
Tkac et al.
Ther Adv Respir Dis 2007;1:47-59.
ABSTRACT  

Assessment Tools for Chronic Obstructive Pulmonary Disease: Do Newer Metrics Allow For Disease Modification?
Mahler and Criner
Proc Am Thorac Soc 2007;4:507-511.
ABSTRACT | FULL TEXT  

Pharmacologic Therapy: Novel Approaches for Chronic Obstructive Pulmonary Disease
Bailey and Tashkin
Proc Am Thorac Soc 2007;4:543-548.
ABSTRACT | FULL TEXT  

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary
Rabe et al.
Am. J. Respir. Crit. Care Med. 2007;176:532-555.
ABSTRACT | FULL TEXT  

Linking Parenchymal Disease Progression to Changes in Lung Mechanical Function by Percolation
Bates et al.
Am. J. Respir. Crit. Care Med. 2007;176:617-623.
ABSTRACT | FULL TEXT  

Inflammation in COPD: a link to systemic comorbidities
Rennard
ERR 2007;16:91-97.
ABSTRACT | FULL TEXT  

Where current pharmacological therapies fall short in COPD: symptom control is not enough
Roche
ERR 2007;16:98-104.
ABSTRACT | FULL TEXT  

Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Gamble et al.
Eur Respir J 2007;30:467-471.
ABSTRACT | FULL TEXT  

Chronic Obstructive Pulmonary Disease and Premature Aging
Vogelmeier and Bals
Am. J. Respir. Crit. Care Med. 2007;175:1217-1218.
FULL TEXT  

Polymorphisms of interleukin-10 and its receptor and lung function in COPD
He et al.
Eur Respir J 2007;29:1120-1126.
ABSTRACT | FULL TEXT  

Effectiveness of biomedical risk assessment as an aid for smoking cessation: a systematic review
Bize et al.
Tobacco Control 2007;16:151-156.
ABSTRACT | FULL TEXT  

Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease: A Roundtable
O'Donnell et al.
Proc Am Thorac Soc 2007;4:145-168.
ABSTRACT | FULL TEXT  

COPD and death: what exactly is the relationship?
Rudolf
Thorax 2007;62:378-379.
FULL TEXT  

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
McGarvey et al.
Thorax 2007;62:411-415.
ABSTRACT | FULL TEXT  

A Pooled Analysis of FEV1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or Placebo
Soriano et al.
Chest 2007;131:682-689.
ABSTRACT | FULL TEXT  

Regular Physical Activity Modifies Smoking-related Lung Function Decline and Reduces Risk of Chronic Obstructive Pulmonary Disease: A Population-based Cohort Study
Garcia-Aymerich et al.
Am. J. Respir. Crit. Care Med. 2007;175:458-463.
ABSTRACT | FULL TEXT  

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
Tonnesen et al.
Eur Respir J 2007;29:390-417.
ABSTRACT | FULL TEXT  

Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers
Tanaka et al.
Eur Respir J 2007;29:34-41.
ABSTRACT | FULL TEXT  

Mortality in COPD: role of comorbidities
Sin et al.
Eur Respir J 2006;28:1245-1257.
ABSTRACT | FULL TEXT  

Pooled Clinical Trial Analysis of Tiotropium Safety
Kesten et al.
Chest 2006;130:1695-1703.
ABSTRACT | FULL TEXT  

Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story.
Mannino
Thorax 2006;61:1032-1034.
FULL TEXT  

Harm from spirometry?
Petty
Chest 2006;130:1629-1630.
FULL TEXT  

Developing COPD: a 25 year follow up study of the general population.
Lokke et al.
Thorax 2006;61:935-939.
ABSTRACT | FULL TEXT  

An oral selective M3 cholinergic receptor antagonist in COPD
Lu et al.
Eur Respir J 2006;28:772-780.
ABSTRACT | FULL TEXT  

Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction.
Innes et al.
Chest 2006;130:1102-1108.
ABSTRACT | FULL TEXT  

Smoking cessation counseling: a practice management perspective.
Pohlig
Chest 2006;130:1231-1233.
ABSTRACT | FULL TEXT  

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
Man et al.
Thorax 2006;61:849-853.
ABSTRACT | FULL TEXT  

Smokers with airway obstruction are more likely to quit smoking
Bednarek et al.
Thorax 2006;61:869-873.
ABSTRACT | FULL TEXT  

Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis
Barr et al.
Thorax 2006;61:854-862.
ABSTRACT | FULL TEXT  

Technical and functional assessment of 10 office spirometers: a multicenter comparative study.
Liistro et al.
Chest 2006;130:657-665.
ABSTRACT | FULL TEXT  

Pharmacotherapy for Mortality Reduction in Chronic Obstructive Pulmonary Disease
Sin and Man
Proc Am Thorac Soc 2006;3:624-629.
ABSTRACT | FULL TEXT  

Economic Modeling in Chronic Obstructive Pulmonary Disease
Rutten-van Molken and Lee
Proc Am Thorac Soc 2006;3:630-634.
ABSTRACT | FULL TEXT  

Nurse-Conducted Smoking Cessation in Patients With COPD, Using Nicotine Sublingual Tablets and Behavioral Support.
Pbert
Chest 2006;130:314-316.
FULL TEXT  

Nurse-Conducted Smoking Cessation in Patients With COPD Using Nicotine Sublingual Tablets and Behavioral Support.
Tonnesen et al.
Chest 2006;130:334-342.
ABSTRACT | FULL TEXT  

Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France.
Guenegou et al.
J. Med. Genet. 2006;43:e43-e43.
ABSTRACT | FULL TEXT  

Pulmonary Function after Exposure to the World Trade Center Collapse in the New York City Fire Department
Banauch et al.
Am. J. Respir. Crit. Care Med. 2006;174:312-319.
ABSTRACT | FULL TEXT  

Nicotine replacement therapy for long-term smoking cessation: a meta-analysis.
Etter and Stapleton
Tobacco Control 2006;15:280-285.
ABSTRACT | FULL TEXT  

Advanced emphysema in african-american and white patients: do differences exist?
Chatila et al.
Chest 2006;130:108-118.
ABSTRACT | FULL TEXT  

Prevention of Exacerbations: How Are We Doing and Can We Do Better?
Burge
Proc Am Thorac Soc 2006;3:257-261.
ABSTRACT | FULL TEXT  

Chronic Obstructive Pulmonary Disease: Linking Outcomes and Pathobiology of Disease Modification
Rennard
Proc Am Thorac Soc 2006;3:276-280.
ABSTRACT | FULL TEXT  

Prevalence of COPD in Women Compared to Men Around the Time of Diagnosis of Primary Lung Cancer
Loganathan et al.
Chest 2006;129:1305-1312.
ABSTRACT | FULL TEXT  

Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
Jones and Agusti
Eur Respir J 2006;27:822-832.
ABSTRACT | FULL TEXT  

The natural history of chronic obstructive pulmonary disease.
Mannino et al.
Eur Respir J 2006;27:627-643.
FULL TEXT  

Chronic obstructive pulmonary disease: current burden and future projections
Lopez et al.
Eur Respir J 2006;27:397-412.
FULL TEXT  

Relation between duration of smoking cessation and bronchial inflammation in COPD
Lapperre et al.
Thorax 2006;61:115-121.
ABSTRACT | FULL TEXT  

Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium
Niewoehner et al.
ANN INTERN MED 2006;144:148-149.
FULL TEXT  

Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based Optimism.
Celli
Proc Am Thorac Soc 2006;3:58-65.
ABSTRACT | FULL TEXT  

Chronic Cough Due to Chronic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines
Braman
Chest 2006;129:104S-115S.
ABSTRACT | FULL TEXT  

COPD disease progression and airway inflammation: uncoupled by smoking cessation
Ind
Eur Respir J 2005;26:764-766.
FULL TEXT  

Chronic Obstructive Pulmonary Disease Outcome Measurements: What's Important? What's Useful?
Gross
Proc Am Thorac Soc 2005;2:267-271.
ABSTRACT | FULL TEXT